Leerink Partnrs reissued their outperform rating on shares of AnaptysBio (NASDAQ:ANAB – Free Report) in a research report released on Tuesday morning, Zacks.com reports. Leerink Partnrs also issued estimates for AnaptysBio’s Q1 2024 earnings at ($1.41) EPS, Q2 2024 earnings at ($1.44) EPS, Q3 2024 earnings at ($1.45) EPS, Q4 2024 earnings at ($1.42) EPS, […]
SG Americas Securities LLC bought a new position in AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,875 shares of the biotechnology company’s stock, valued at approximately $126,000. Other large investors also recently modified their […]
AnaptysBio (NASDAQ:ANAB) Trading Up 3 6% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
JPMorgan Chase & Co Trims AnaptysBio (NASDAQ:ANAB) Target Price to $28 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $23.35, but opened at $26.90. AnaptysBio shares last traded at $25.44, with a volume of 60,543 shares changing hands. Analyst Ratings Changes ANAB has been the topic of several research analyst reports. […]